How does aspirin affect surgical bleeding?

How long does aspirin’s effect on bleeding last after stopping it?
Aspirin irreversibly blocks platelet COX-1 for the life of the platelet, so the antiplatelet action persists for 7–10 days after the last dose, roughly the time it takes for new platelets to replace the inhibited ones. Surgeons commonly ask patients to stop aspirin 7–10 days before elective procedures to restore normal clotting.

What happens to bleeding risk if aspirin is continued through surgery?
Continuing aspirin raises intraoperative and postoperative bleeding volume and transfusion need, especially in procedures with high vascular exposure such as cardiac, orthopedic, and neurosurgery. The absolute increase in major bleeding is usually modest (a few milliliters to a few hundred milliliters) yet clinically relevant when blood loss is already expected to be high.

How do surgeons balance aspirin’s cardiovascular protection against bleeding risk?
Guidelines weigh the indication for aspirin. In patients with recent stents or high ischemic risk, many centers keep aspirin through surgery and accept the modest bleeding increase; in low-risk patients having low-bleed procedures, stopping aspirin is preferred. Decision tools such as the ACC/AHA perioperative algorithm help quantify this trade-off.

Are there ways to reverse aspirin’s effect quickly before an urgent operation?
No pharmacologic antidote exists. Platelet transfusion can supply functional platelets, but it is used only when bleeding is active and life-threatening because transfused platelets themselves can become inhibited if aspirin is still circulating. Desmopressin and tranexamic acid are sometimes added as adjuncts, though evidence for rapid reversal is limited.

How do newer antiplatelet agents compare with aspirin regarding perioperative bleeding?
P2Y12 inhibitors such as clopidogrel and ticagrelor produce more profound and sometimes longer platelet inhibition than aspirin alone. Guidelines therefore recommend longer washout periods (5–7 days for clopidogrel, 3–5 days for ticagrelor) and often favor staged interruption strategies when dual therapy is required.

When does aspirin’s patent protection end and what does that mean for cost?
Aspirin lost patent protection decades ago; generic tablets are widely available for pennies per dose. This low cost makes aspirin the default antiplatelet agent in most health systems, but it also means manufacturers have little incentive to fund large perioperative trials, leaving clinicians to rely on observational data and consensus guidelines.